Netherlands· NL-fef5c28f477a

Aprovel 300 mg, tabletten

A irbesartan product containing irbesartan, registered in Netherlands by Sanofi Winthrop Industrie. The same ATC class is registered in 18 of our 19 countries.

ATC C09CA04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about irbesartanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Irbesartan is registered in 18 of 19 countries.

Countries holding a registration under ATC C09CA04 (irbesartan), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search irbesartan products by name

Irbesartan · ATC C09CA04

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of irbesartan costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.14 in France to $0.68 in Switzerland — a ×4.7 gap.

5 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Irbesartan · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

CH Switzerland$0.68
ES Spain$0.31
IT Italy$0.26
US United States$0.16 (acquisition cost)
FR France$0.14

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: IRBESARTAN
Manufacturer: Sanofi Winthrop Industrie
Country: Netherlands (NL)
ATC code: C09CA04
ATC class: Irbesartan
Defined daily dose: 0.15 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/97/046

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

371 interactions on record for irbesartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check irbesartan against other medicines How interaction checks work

Irbesartan · interactions on record

371 records

7 severe
128 moderate
3 minor
152 info

Most severe, free to view

Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
Potassium gluconateA12BA05severe
Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Irbesartan in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All irbesartan products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

Austria · Irbepress, Irbesartan Hexal
Belgium · Irbesartan Eg, Irbesartan Sandoz
Bulgaria · Ирбесан, Ирбесо
Cyprus · Converium, Irbesartan Vocate
Czechia · Isame
Germany · Irbepress, Irbesartan 1 A Pharma
Denmark · Irbesartan Accord, Irbesartan Jubilant
Spain · Irbesartán Almus, Irbesartán Alter
France · Irbesartan Accord, Irbesartan Arrow
United Kingdom (Northern Ireland) · Irbesartan, Irbesartan Accord
Greece · Besartan, Irbegen
Hungary · Irabel, Irbesartan Sandoz
Ireland · Irbesartan Clonmel, Irbesartan Rowa
Iceland · Aprovel, Ifirmasta
Italy · Abesart, Irbesartan Accord
Liechtenstein · Aprovel, Irbesartan Teva
Luxembourg · Irbesartan Eg, Irbesartan Viatris
Malta · Irbesartan Aurobindo Pharma (Malta)
Norway · Aprovel, Ifirmasta
Poland · Irbesartan Aurovitas
Portugal · Irbesartan Alter, Irbesartan Aurovitas
Romania · Irbesartan Terapia
Sweden · Irbesartan Accord, Irbesartan Actavis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/8be44170-aa8a-4987-9e50-0e4d2cfe55ae
GET /v1/drugs/8be44170-aa8a-4987-9e50-0e4d2cfe55ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/aprovel-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Irbesartan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70143",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "POLOXAMEER 188",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "IRBESARTAN"
  ],
  "leaflet_url": null,
  "authorised_at": "1997/08/27",
  "procedure_number": "EMEA/H/C/000141",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/97/046",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about irbesartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console